Blog: Anapol Weiss

Anapol Weiss is a top-rated national personal injury firm with a reputation for winning big. Our trial attorneys are leaders in medical malpractice, women's health litigation, personal injury, and mass torts cases. As a female majority-owned firm with a deep bench of experienced, determined trial attorneys, we are compassionate with our clients and fierce in the courtroom.
- U.S. News and The Guardian Report: Depo-Provera Associated with an Increased Risk of Tumors
Oct 28, 2024
The excerpts below from The Guardian and U.S. News provide essential information about the French study, announced in March 2024, that found an increased risk of brain and spinal cord tumors to be associated with prolonged Depo-Provera use. The study is referenced in Depo Provera brain tumor lawsuits filed against pharmaceutical manufacturer Pfizer. Anapol Weiss filed its first complaint against Pfizer on October 28, 2024, on behalf of a California woman who used Depo-Provera over...Read More - A Lifetime of Legal Battles Against Dangerous Products
Oct 10, 2024
Tracy Finken Magnotta, Anapol Weiss Women’s Health Ligitation Team I Have Spent My Career Holding Companies Accountable for Marketing Unsafe Products and Failing to Disclose the Serious Risks to Consumers However, time and again, we see these companies prioritizing profits over safety. Billion-dollar products are marketed without proper warnings and the result is often catastrophic. Over the past 25 years, I have been passionate about representing women and children for the life-changing injuries they have sustained and...Read More - Depo Provera Long Term Side Effects & How to File a Lawsuit
Oct 9, 2024
Depo-Provera (medroxyprogesterone acetate), a long-acting contraceptive injection, is used by millions of women worldwide. While exact numbers can vary by region and over time, as of recent estimates: Global use: Around 20 million women worldwide have used Depo-Provera. United States: Approximately 1.6 million women use Depo-Provera in the U.S. annually. This accounts for about 3% of women using contraception in the country. Recent research has exposed serious Depo Provera long term side effects, giving rise to legal action...Read More - Pfizer and Depo-Provera: Another Example of a Company Failing to Warn Women About Risks in Products and Medicines
Oct 7, 2024
In recent years, there has been a growing awareness of how certain companies have failed to adequately warn female consumers about the risks associated with their products and medicines. From pharmaceuticals to cosmetics, several high-profile cases have highlighted the negligence of corporations in protecting women’s health. The most recent example is Pfizer’s failure to warn millions of users of Depo-Provera about the injection’s increased risk of causing brain and spinal cord tumors (meningiomas). When research revealed...Read More - Depo Provera Shot Lawsuit: Law.com Interviews Anapol Weiss Shareholder Kila Baldwin
Oct 7, 2024
Published in Law.com Written By: Amanda Bronstad Kila Baldwin is one of the leaders of the Anapol Weiss Women’s Health Litigation Team. She is currently preparing Depo Provera shot lawsuit cases. By filing Depo Provera shot lawsuit complaints against Pfizer on behalf of women who have had brain or spinal cord tumors (meningiomas) and who were on Depo-Provera for a year or more, she and her colleagues are standing up for the rights and safety of women.] Excerpts...Read More - Informed Consent and Depo-Provera: Are Women Being Properly Informed?
Oct 7, 2024
Women deserve the right to make choices about their health, but only through full and accurate warnings and drug information can any woman make the decision that’s right for her. Women who aren’t properly informed about the risks of their birth control medications could be taking on serious health risks without even knowing it. That, along with the severe harm that has been linked to birth control injections in the form of an increased risk...Read More - Depo Shot Lawsuit: Yet Another Example of Women Fighting Back Against Harmful Drugs
Oct 4, 2024
By: Anapol Weiss Women’s Health Litigation Team Depo-Provera, the popular injectable contraceptive containing medroxyprogesterone acetate, has been marketed as a safe, convenient, long-term birth control solution. However, recent research has linked it to an increased risk of brain and spinal cord tumors (“meningiomas”), resulting in the filing of Depo shot lawsuit claims. If you have been diagnosed with a brain tumor after using Depo-Provera, you may have legal recourse through the Depo Provera class action lawsuit...Read More - Health Implications: How the Depo-Provera Lawsuit Highlights Women's Health Concerns
Oct 4, 2024
The birth control shot, a contraceptive delivered by injection every 12 weeks, has been hailed as a convenient alternative for women who don’t want to take birth control pills daily. Unfortunately, recent research findings have raised serious concerns about the safety of this medication. The recent Depo-Provera lawsuits are the latest mass tort legislation arising out of women’s health concerns. For patients who did or currently do use Depo-Provera for birth control, it’s important to understand...Read More - Recreational Helmets: Design Defects—Bicycle, Football and Motorcycling
Sep 30, 2024
Published in The Legal Intelligencer September 30, 2024 By Larry Coben, Anapol Weiss Excerpts from the article: No one has ever attempted any sort of retrospective study of the relationship between helmet design and the frequency or nature of injury. And yet the issue of the efficacy of helmet safety effects millions of Americans. Approximately 47 million Americans bicycle on a regular basis. In 2015, in the United States, over 1,000 bicyclists died and there were almost 338,000 bicycle-related injuries...Read More - Female Patients at Jefferson Health Hospital are Forced to Cope with the Consequences of Incorrect Mammogram Result Failures
Sep 26, 2024
Jefferson Einstein Philadelphia, formerly Einstein Medical Center, was recently cited by local health inspectors for providing incorrect mammogram results to patients. Sarah Gantz authored an article for the Philadelphia Inquirer dated September 26, 2024, wherein she describes how Jefferson Einstein (“Einstein”) incorrectly informed patients their mammogram results showed “no sign of breast cancer.” However, these patients subsequently learned the results were inconclusive requiring follow-up. This news comes after at least two women have reported receiving incorrect...Read More
